Lourdes Pablo

562 total citations
14 papers, 463 citations indexed

About

Lourdes Pablo is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Lourdes Pablo has authored 14 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Oncology. Recurrent topics in Lourdes Pablo's work include Glycosylation and Glycoproteins Research (3 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Cancer Mechanisms and Therapy (2 papers). Lourdes Pablo is often cited by papers focused on Glycosylation and Glycoproteins Research (3 papers), Toxin Mechanisms and Immunotoxins (2 papers) and Cancer Mechanisms and Therapy (2 papers). Lourdes Pablo collaborates with scholars based in United States, United Kingdom and Poland. Lourdes Pablo's co-authors include Neil E. Simister, Patricia McCoon, Donatella Barisani, Richard S. Blumberg, Craig M. Story, Véronique Bailly, Steven D. Miklasz, Paul D. Rennert, Zhifang Li and Irene Sizing and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Lourdes Pablo

13 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lourdes Pablo United States	8	283	177	106	94	56	14	463
David Plows Greece	8	159 0.6×	186 1.1×	66 0.6×	141 1.5×	81 1.4×	9	504
Eyal Fima Israel	13	248 0.9×	336 1.9×	44 0.4×	139 1.5×	43 0.8×	23	645
Isaac J. Rondon United States	12	290 1.0×	164 0.9×	119 1.1×	68 0.7×	103 1.8×	14	615
Dalia Gilat Israel	10	170 0.6×	181 1.0×	45 0.4×	85 0.9×	58 1.0×	14	510
S. J. Gadd Austria	9	162 0.6×	164 0.9×	82 0.8×	80 0.9×	46 0.8×	13	478
Vibeke Sundvold‐Gjerstad Norway	13	272 1.0×	247 1.4×	40 0.4×	117 1.2×	47 0.8×	22	506
Eric E. Williams United States	6	153 0.5×	143 0.8×	90 0.8×	186 2.0×	48 0.9×	6	433
Anil K. Panigrahi United States	17	446 1.6×	255 1.4×	41 0.4×	55 0.6×	64 1.1×	29	849
Przemysław Janik Poland	11	254 0.9×	77 0.4×	46 0.4×	117 1.2×	57 1.0×	28	471
Masaharu Hatakeyama Japan	15	155 0.5×	452 2.6×	39 0.4×	183 1.9×	57 1.0×	24	634

Countries citing papers authored by Lourdes Pablo

Since Specialization

Citations

This map shows the geographic impact of Lourdes Pablo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lourdes Pablo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lourdes Pablo more than expected).

Fields of papers citing papers by Lourdes Pablo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lourdes Pablo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lourdes Pablo. The network helps show where Lourdes Pablo may publish in the future.

Co-authorship network of co-authors of Lourdes Pablo

This figure shows the co-authorship network connecting the top 25 collaborators of Lourdes Pablo. A scholar is included among the top collaborators of Lourdes Pablo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lourdes Pablo. Lourdes Pablo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Woessner, Rich, Vasu R. Sah, Patricia McCoon, et al.. (2017). Abstract 3684: Inhibition of STAT3 by antisense oligonucleotide treatment decreases the immune suppressive tumor microenvironment in syngeneic and GEM tumor models. Cancer Research. 77(13_Supplement). 3684–3684. 1 indexed citations

Woessner, Richard, Patricia McCoon, Shaun Grosskurth, et al.. (2015). Abstract A94: STAT3 antisense treatment decreases M2 macrophage infiltration and enhances the activity of checkpoint inhibitors in preclinical tumor models. Molecular Cancer Therapeutics. 14(12_Supplement_2). A94–A94. 2 indexed citations

Woessner, Rich, Patricia McCoon, Kirsten Bell, et al.. (2015). Abstract A93: STAT3 inhibition enhances the activity of immune checkpoint inhibitors in murine syngeneic tumor models by creating a more immunogenic tumor microenvironment. Cancer Immunology Research. 3(10_Supplement). A93–A93. 2 indexed citations

McEachern, Kristen, Adriana E. Tron, Greg O’Connor, et al.. (2014). Preclinical and Clinical Pharmacodynamics of Pan-Pim Inhibition By AZD1208 in Acute Myeloid Leukemia: Assessment of Pim Isoform Dependency for Bad and 4EBP1 Phosphorylation. Blood. 124(21). 906–906.

McEachern, Kristen, Yichen Cao, Rachel DuPont, et al.. (2013). Abstract 3516: AZD1208 PIM kinase inhibitor - Preliminary evidence of target pathway inhibition in Phase I clinical trials of AML.. Cancer Research. 73(8_Supplement). 3516–3516. 1 indexed citations

Brown, Jeffrey L., Zhe Cao, Maria Pinzon-Ortiz, et al.. (2010). A Human Monoclonal Anti-ANG2 Antibody Leads to Broad Antitumor Activity in Combination with VEGF Inhibitors and Chemotherapy Agents in Preclinical Models. Molecular Cancer Therapeutics. 9(1). 145–156. 113 indexed citations

Pinzon-Ortiz, Maria, Alex Cao, Lourdes Pablo, et al.. (2010). Abstract 4429: Characterization of the kinesin spindle protein inhibitor AZD4877. Cancer Research. 70(8_Supplement). 4429–4429. 2 indexed citations

Sizing, Irene, Véronique Bailly, Patricia McCoon, et al.. (2007). Epitope-Dependent Effect of Anti-Murine TIM-1 Monoclonal Antibodies on T Cell Activity and Lung Immune Responses. The Journal of Immunology. 178(4). 2249–2261. 66 indexed citations

Rennert, Paul D., Takaharu Ichimura, Irene Sizing, et al.. (2006). T Cell, Ig Domain, Mucin Domain-2 Gene-Deficient Mice Reveal a Novel Mechanism for the Regulation of Th2 Immune Responses and Airway Inflammation. The Journal of Immunology. 177(7). 4311–4321. 64 indexed citations

10.

Grueneberg, Dorre A., Lourdes Pablo, Kang‐Quan Hu, et al.. (2003). A Functional Screen in Human Cells Identifies UBF2 as an RNA Polymerase II Transcription Factor That Enhances the β-Catenin Signaling Pathway. Molecular and Cellular Biology. 23(11). 3936–3950. 23 indexed citations

11.

Weng, Zhigang, Mei Xin, Lourdes Pablo, et al.. (2002). Protection against Anoikis and Down-regulation of Cadherin Expression by a Regulatable β-Catenin Protein. Journal of Biological Chemistry. 277(21). 18677–18686. 33 indexed citations

12.

Mikulska, J, et al.. (2000). Cloning and analysis of the gene encoding the human neonatal Fc receptor. European Journal of Immunogenetics. 27(4). 231–240. 26 indexed citations

13.

Wang, Yang, Kelli Kachel, Lourdes Pablo, & Erwin London. (1997). Use of Trp Mutations To Evaluate the Conformational Behavior and Membrane Insertion of A and B Chains in Whole Diphtheria Toxin. Biochemistry. 36(51). 16300–16308. 13 indexed citations

14.

Blumberg, Richard S., et al.. (1995). A major histocompatibility complex class I-related Fc receptor for IgG on rat hepatocytes.. Journal of Clinical Investigation. 95(5). 2397–2402. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact